Scientists investigate why cancer drugs turn immune system against body
NCT ID NCT04119713
Summary
This study aims to understand why some cancer patients develop autoimmune side effects when taking immunotherapy drugs called checkpoint inhibitors. Researchers will collect blood samples from 600 cancer patients before and during their immunotherapy treatment to study their immune system genetics and responses. The goal is to identify which patients are most at risk for these side effects and why they occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania - Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Conditions
Explore the condition pages connected to this study.